Stay updated with breaking news from Renal Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India Business News: Sun Pharma and Bayer have entered into an agreement to market and distribute a second brand of the patented medicine Finerenone in India. Finerenone i
1. Patients with chronic kidney disease (CKD) who used Decision-Aid for Renal Therapy (DART) demonstrated improved decision quality compared to those receiving care as usual. 2. Patients who used DART had increased knowledge regarding treatment options compared to those who received care as usual. Evidence Rating Level: 1 (Excellent) Study Rundown: Individuals with advanced CKD
A decision aid increase older adults' knowledge about renal replacement therapy (RRT) for CKD.
Study results suggest that many older patients with chronic kidney disease do not have an opportunity for shared decision making when contemplating dialysis.
A qualitative study identified obstacles to successful telehealth use for the care of older patients with advanced chronic kidney disease.